TrialThe New England journal of medicine2024
Oral Nirmatrelvir-Ritonavir as Postexposure Prophylaxis for Covid-19.
Jennifer Hammond et al.PubMed ↗Full text ↗Publisher ↗
No numbers read from the abstract.
22 papers cite it
this papertrialcites it
TrialThe New England journal of medicine2024
Jennifer Hammond et al.PubMed ↗Full text ↗Publisher ↗
No numbers read from the abstract.